FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Bayer Wins FDA Clearance of myBETAapp and Betaconnect Navigator

June 1, 2017
A A

The FDA has approved Bayer’s supplemental Biologics License Application for myBETAapp and the Betaconnect navigator.

The autoinjector is used to administer Betaseron (interferon beta-1b) which uses bluetooth to connect the autoinjector to the new myBETAapp on a mobile device or computer.

Betaseron is a prescription medicine used to reduce relapses in individuals with relapsing forms of multiple sclerosis. — Cynthia Jessup

View today's stories